Cargando…
Glucagon-like peptide-1 enhances cardiac L-type Ca(2+ )currents via activation of the cAMP-dependent protein kinase A pathway
BACKGROUND: Glucagon-like peptide-1 (GLP-1) is a hormone predominately synthesized and secreted by intestinal L-cells. GLP-1 modulates multiple cellular functions and its receptor agonists are now used clinically for diabetic treatment. Interestingly, preclinical and clinical evidence suggests that...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037307/ https://www.ncbi.nlm.nih.gov/pubmed/21251280 http://dx.doi.org/10.1186/1475-2840-10-6 |